Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjian Yang

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Clinical Breast Cancer|May 17, 2020
Research Progress on Long Non-coding RNAs and Drug Resistance of Breast CancerXiping Zhang, Hongjian Yang
Oncology Letters|July 3, 2015
Integrated analysis of differentially expressed genes in breast cancer pathogenesisDaobao Chen, Hongjian Yang
Bioscience Reports|August 8, 2019
Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactionsXiping Zhang, Hongjian Yang, Ruiping Zhang
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 26, 2018
The Expanding Utility of Rhodium-Iminocarbenes: Recent Advances in the Synthesis of Natural Products and Related ScaffoldsYun Li, Hongjian Yang, Hongbin Zhai
Cancer Management and Research|March 5, 2021
Dissection of Level III Axillary Lymph Nodes in Breast CancerJiejie Hu, Xianghou Xia, Hongjian Yang, et al.
Artificial Intelligence in Medicine|March 4, 2022
ISSMF: Integrated semantic and spatial information of multi-level features for automatic segmentation in prenatal ultrasound imagesYihao Sun, Hongjian Yang, Jiliu Zhou, et al.
Frontiers in Molecular Biosciences|May 1, 2023
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancerYeqin Fu, Qiuhui Yang, Hongjian Yang, et al.
Breast Cancer Research and Treatment|March 3, 2009
Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor statusMin Zhang, Hongjian Yang, C D'Arcy J Holman
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 4, 2014
[Pregnancy and breast cancer]Xianghui Du, Yaping Xu, Hongjian Yang, et al.
Frontiers in Pharmacology|October 10, 2022
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategiesXiaofan Wu, Hongjian Yang, Xingfei Yu, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Clinical Breast Cancer|May 17, 2020
Research Progress on Long Non-coding RNAs and Drug Resistance of Breast CancerXiping Zhang, Hongjian Yang
Oncology Letters|July 3, 2015
Integrated analysis of differentially expressed genes in breast cancer pathogenesisDaobao Chen, Hongjian Yang
Bioscience Reports|August 8, 2019
Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactionsXiping Zhang, Hongjian Yang, Ruiping Zhang
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 26, 2018
The Expanding Utility of Rhodium-Iminocarbenes: Recent Advances in the Synthesis of Natural Products and Related ScaffoldsYun Li, Hongjian Yang, Hongbin Zhai
Cancer Management and Research|March 5, 2021
Dissection of Level III Axillary Lymph Nodes in Breast CancerJiejie Hu, Xianghou Xia, Hongjian Yang, et al.
Artificial Intelligence in Medicine|March 4, 2022
ISSMF: Integrated semantic and spatial information of multi-level features for automatic segmentation in prenatal ultrasound imagesYihao Sun, Hongjian Yang, Jiliu Zhou, et al.
Frontiers in Molecular Biosciences|May 1, 2023
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancerYeqin Fu, Qiuhui Yang, Hongjian Yang, et al.
Breast Cancer Research and Treatment|March 3, 2009
Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor statusMin Zhang, Hongjian Yang, C D'Arcy J Holman
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 4, 2014
[Pregnancy and breast cancer]Xianghui Du, Yaping Xu, Hongjian Yang, et al.
Frontiers in Pharmacology|October 10, 2022
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategiesXiaofan Wu, Hongjian Yang, Xingfei Yu, et al.
Pageof 15